Pharmacy Website
Clinic Website

Intelligence » Top Posts » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Infant Ibuprofen Recalled From Walmart, CVS, Family Dollar Over Fears of High Dosage

Thursday, December 06, 2018 -- Tris Pharma, Inc. issued a recall on three lots of infant ibuprofen.

Some dog food has toxic levels of vitamin D, FDA warns

Tuesday, December 04, 2018 -- More brands may be recalled as the FDA tests them.

FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod)

Monday, December 03, 2018 -- FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod)

FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)

Tuesday, December 04, 2018 -- The U.S. Food and Drug Administration (FDA) is warning that rare but serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after they received Lemtrada (alemtuzumab).

Tris Pharma Issues Recall of Infants' Concentrated Oral Suspension Ibuprofen

Wednesday, December 05, 2018 -- NewsThe voluntary recall involves three lots, 50 mg per 1.25 mL, that may have higher concentrations of ibuprofen.Contributed Author: Tris Pharma, Inc.Topics: Recalls

Kroger Louisville Division Recalls Abound Chicken and Brown Rice Dog Food Because of Elevated Vitamin D Levels

Thursday, December 06, 2018 -- Following a recall by Sunshine Mills, Inc., the Kroger Louisville division announced it has removed from sale Abound Chicken & Brown Rice Recipe dog food produced by the supplier. The dog food was sold in one Kroger store located at 2440 Bardstown Road in Louisville, KY. Only Abound Chicken & Brown Rice Recipe dog food with the listed UPC numbers and Best by Dates are affected by this recall. The recall was initiated because the product had the potential to contain an elevated level of Vitamin D, which may cause renal failure.

Mylan to recall all batches of blood pressure medicine valsartan in U.S.

Tuesday, December 04, 2018 -- Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches.

Supernus Pharma's ADHD treatment fails to impress; shares fall

Thursday, December 06, 2018 -- Supernus Pharmaceuticals Inc's treatment for attention deficit hyperactivity disorder met the main goal of two trials, but shares fell about 16 percent on Thursday as the data failed to convince some investors that the drug was better than rivals.

ASH: Johnson & Johnson's fast-growing Darzalex lines up for 2nd front-line myeloma OK

Tuesday, December 04, 2018 -- Johnson & Johnson’s Darzalex made multiple myeloma history in May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, armed with a new batch of data, it’s looking for a repeat.

Bauer’s Candies’ Modjeskas May Be Contaminated with Hepatitis A

Friday, December 07, 2018 -- The FDA has issued a public health alert about possible hepatitis A contamination in Bauer’s Candies’ Modjeskas. This product is individually wrapped marshmallow candy that is dipped in chocolate or caramel. A worker in the facility tested positive for hepatitis A. These Modjeskas candy products are available at retail stores throughout the country and can […] The post Bauer’s Candies’ Modjeskas May Be Contaminated with Hepatitis A appeared first on Food Poisoning Bulletin.

Novartis's new treatment for hives outperforms Xolair in trials

Tuesday, December 04, 2018 -- Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria, also known as hives.

Roche's Tecentriq wins speedy U.S. FDA review for small cell lung cancer

Wednesday, December 05, 2018 -- Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has been trailing rivals' revenues.

Elderly in nursing homes have 40% higher risk for antibiotic-resistant UTIs

Thursday, December 06, 2018 -- Elderly residents of nursing homes had an approximately 40% higher risk for developing antibiotic-resistant Enterobacteriaceae urinary tract infections than peers who lived in the community, according to study findings from France that were published in the Journal of Antimicrobial Chemotherapy.Céline Pulcini, MD, PhD , a professor of infectious diseases at Nancy University Hospital and the University of Lorraine, and colleagues analyzed 19,471 antibiotic susceptibility tests from urine samples that were culture positive for Escherichia coli (85.4%), Proteus mirabilis (5.7%) and

Psoriasis: Experimental Use of Lipid Molecule to Supress Inflammation

Tuesday, December 04, 2018 -- Phosphatidylglycerol may be appropriate to develop for use as a treatment for psoriasis. Continue reading →

Sanofi merges biology and tech with research deal for digital asthma lab

Wednesday, December 05, 2018 -- Sanofi plans to take asthma research where it has not gone before. A new partnership with Mount Sinai Health System and advanced analytics firm Sema4 will create a digital asthma laboratory.

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial

Tuesday, December 04, 2018 -- Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved survival in blood cancer patients, compared with drugs currently used as the standard of care.

Roche's lung cancer combo treatment wins FDA approval

Thursday, December 06, 2018 -- Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.

U.S. FDA removes safety warning from Smith & Nephew's diabetic gel

Wednesday, December 05, 2018 -- British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.

Novartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3

Thursday, December 06, 2018 -- With blockbuster Xolair aging, Novartis is looking to usher in a follow-up drug to keep that franchise growing, and it got one step closer this week. Armed with Xolair-topping phase 2 data, the Swiss drugmaker will push hives treatment candidate ligelizumab into phase 3.

Can Topical Drugs Help Prevent Breast Cancer?

Tuesday, December 04, 2018 -- Researchers are testing a topical-gel form of the drug tamoxifen to see if it can help prevent breast cancer as effectively as the oral form of the drug but with fewer side effects.